Jump to navigation
Have a comment, complaint, or compliment? We want to hear from you.
PeerVoice invites you to explore the education and resources on this site that provides a comprehensive approach to managing your patients
User-friendly learning modules available in short and accessible formats.
Insights and developments from leading experts.
Continuously updated news and conference coverage.
Helpful resources for your practice and patients.
Canakinumab for the Treatment of Auto-Inflammatory Recurrent Fever Syndromes
De Benedetti F et al. N Engl J Med. 2018;378:1908-1919
Treating Juvenile Idiopathic Arthritis to Target: Recommendations of an International Task Force
Ravelli A et al. Ann Rheum Dis. 2018;77:819-828
Validation of the Auto-Inﬂammatory Diseases Activity Index (AIDAI) for Hereditary Recurrent Fever Syndromes
Piram M et al. Ann Rheum Dis. 2014;73:2168-2173
Neonatal-Onset Multisystem Inflammatory Disease Responsive to Interleukin-1β Inhibition
Goldbach-Mansky R et al. N Engl J Med. 2006;355:581-592
Current Understanding of the Pathophysiology of Systemic Juvenile Idiopathic Arthritis (sJIA) and Target-Directed Therapeutic Approaches
Bruck N et al. Clin Immunol. 2015;159:72-83
This activity is supported by funding from Novartis Pharma AG.